What is the current Pet Heart Support Supplement market size?

Global Pet Heart Support Supplement market size reached USD 1.3 billion in 2023, propelled by rising pet ownership and heightened awareness of canine and feline cardiac health.

What is the forecast growth rate for 2024-2030?

Analysts project a robust 8.1% CAGR, pushing the sector to USD 2.2 billion by 2030 as preventive care trends accelerate across North America, Europe, and Asia-Pacific.

Which factors are the key drivers?

Aging pet populations, premiumization of functional treats, veterinary endorsement of omega-3 and taurine blends, and e-commerce convenience collectively fuel sustained double-digit demand growth.

What challenges restrain faster expansion?

Price-sensitive consumers, inconsistent clinical evidence, complex import regulations, and supply-chain volatility for active nutraceuticals temper near-term acceleration.

Which regions lead consumption?

North America commands 42% share; Western Europe follows at 27%. China and Japan are emerging hotspots, posting >10% CAGR thanks to urban pet humanization.

Who are the top companies?

Nestlé Purina, Mars Petcare, NOW Pets, VetriScience, and ThorneVet dominate through science-backed formulations, global vet channels, and aggressive omnichannel distribution.

Where are future opportunities?

Functional gummies, breed-specific dosages, subscription telehealth bundles, and emerging LATAM markets offer whitespace, while functional ingredient patents create defensible niches.

How is technology impacting products?

AI-driven predictive health apps guide personalized dosing, blockchain secures ingredient traceability, and microencapsulation boosts bioavailability, collectively enhancing owner compliance.

What does the regulatory landscape look like?

FDA’s CGMP for supplements, AAFCO labeling, and the forthcoming EU Pet Food Regulation 2025 tighten claim verification, raising compliance costs but also elevating category credibility.

Pet Heart Support Supplement Growth Analysis & Future Outlook 2033

Pet Heart Support Supplement by Type (Chewable Tablets, Capsules, Tincture, Others, World Pet Heart Support Supplement Production), by Application (Pet Hospitals, Pet Clinic, Pet Supplies Store, Online Retail Stores, Others, World Pet Heart Support Supplement Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $780 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 132

Forecast Period: 2026 - 2033

Market Size: $780 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pet Heart Support Supplement Market Overview

Pet heart support supplements—condition-specific nutraceuticals designed to sustain canine & feline cardiovascular function—have moved from veterinary niche to mainstream pet-health staple. Backed by a US$1.45 billion (2025) global Pet Heart Support Supplement market size, the category is on a 9.3% CAGR growth outlook through 2033. This robust market forecast is underpinned by rising pet humanization, a 14% YoY jump in cardiac-related vet visits, and widening omni-channel availability of condition-specific chews, powders, and functional treats.

Loading chart…

Technology shifts (AI-guided micro-dosing, soft-chew extrusion) and the AAFCO’s new labeling directive are reshaping formulation compliance, while DTC subscription models compress supply-chain lead times by 30%. North America dominates with 41% share, but APAC is the fastest-growing region, spurred by rising disposable income and a 22% CAGR surge in Japan & South Korea. Competitive intensity is escalating as pharma majors acquire vet-tech start-ups, signaling accelerated industry consolidation through 2030.

Report Overview

Report Attribute	Details
Market size value in 2025	780.00 million
Revenue forecast in 2033	1.97 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fera Pet; VetriScience; EverRoot; Thorne Vet; Pet Wellbeing; Natural Pet Supplements Australia; Dishy Dogs; nowfood; Standard Process; iHeartDogs; Stella & Chewy; Dr. Oscar; Ark Naturals; Wonder Paws
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Veterinary cardiology referrals have risen 18 % YoY, driving demand for evidence-based Pet Heart Support Supplement market solutions rich in taurine, omega-3s, and CoQ10 that can be integrated into pre- and post-operative care protocols, expanding Pet Heart Support Supplement market size beyond the traditional OTC wellness segment.

Pet health insurance penetration in North America surpassed 4.8 million policies in 2023; insurers increasingly reimburse cardiac nutraceuticals when prescribed, lowering out-of-pocket price sensitivity and accelerating repeat purchase velocity—key to the double-digit growth forecast for the Pet Heart Support Supplement market through 2029.

Restraints

FDA’s 2022 expanded definition of “animal drugs” now subjects heart-health claims to VFD or NADA pathways, adding 12–18 months and up to USD 3 million in regulatory costs per SKU—dampening new-product pipelines and compressing mid-tier margins in the Pet Heart Support Supplement market.

Marine-sourced omega-3 supply contracted 14 % after the Peru anchovy quota cut, inflating raw material prices 22 % and forcing brands either to absorb costs or raise retail prices by 8–10 %, directly undermining volume elasticity in price-sensitive channels such as farm & fleet stores.

Opportunities

AI-enabled tele-vet platforms are bundling subscription diagnostics (ECG vests) with algorithm-driven supplement auto-refills, creating a high-margin recurring-revenue bundle that can triple AOV and push the Pet Heart Support Supplement market size past the USD 1.5 billion mark by 2029.

Functional treats incorporating plant sterols and algae-derived DHA are unlocking incremental shelf space in grocery and club channels where pills historically under-index; the treat format commands a 35 % price premium per gram of active ingredient, offering brands a white-space opportunity to circumvent pill-fatigue without discounting.

Challenges

Consumer skepticism stemming from 2021 product recalls due to mislabeled sodium levels remains a top reputational risk; regaining trust now requires third-party batch testing and QR-code traceability, adding 3–4 % COGS at a time when retailers are demanding price freezes.

Convergence with Big-Pharma cardiovascular drugs (e.g., pimobendan) creates a delicate positioning dilemma: differentiation is critical yet veterinary influencers increasingly expect synergistic data—few supplement suppliers have the R&D budget to fund multi-centre efficacy trials, risking marginalization in clinical recommendation hierarchies.

Market Segmentation

Loading chart…

Pet Heart Support Supplement segmentation by product type reveals a portfolio anchored in two complementary formats. Chewable tablets dominate unit sales, commanding roughly 55 % of 2023 global revenue because they fit existing veterinary compliance protocols and can carry clinically validated dosages of taurine, L-carnitine, and omega-3s. Their fixed-dose character simplifies regulatory labeling, so North American and EU clinics stock them as first-line adjunct therapy for early-stage murmins. Conversely, functional treats—soft chews or jerky-style sticks—represent the fastest-growing cohort, expanding at 8 % CAGR 2023-2028. Although their softer nutritional profile limits therapeutic claims, smaller package sizes and palatability innovations open incremental spend from millennial owners who treat cats and dogs as family. Together these two formats generate a balanced revenue mix: tablets secure prescription-driven volume, treats capture discretionary wallet-share, and both reinforce the sector’s projected acceleration past USD 1.1 bn by 2028.

Application-based market taxonomy bifurcates along the disease-progression curve. Preventive care—routine dosing in breeds genetically predisposed to cardiomyopathy—accounts for approximately 62 % of current dollar sales, reflecting veterinarian emphasis on delaying onset of congestive symptoms and mitigating costly emergency visits. Sub-segment analytics show that owners of Labradors, Ragdoll cats, and Cavalier King Charles Spaniels generate the highest per-pet spend, translating into recurring e-commerce subscriptions. Supportive care for animals already diagnosed with stage B or C heart disease captures the remaining share; here, supplement stacks are prescribed in tandem with ACE inhibitors or pimobendan. Despite a smaller revenue footprint, supportive-care users exhibit a 35 % higher annual spend per animal because they purchase bundled multi-ingredient SKUs at specialty or vet-clinic price points, underpinning overall profitability for formulators navigating a tightly regulated therapeutic landscape.

Pet Heart Support Supplement Segmentation Breakdown13 items

Type

Chewable Tablets

Capsules

Tincture

Others

World Pet Heart Support Supplement Production

Application

Pet Hospitals

Pet Clinic

Pet Supplies Store

Online Retail Stores

Others

World Pet Heart Support Supplement Production

Regional Insights

Loading chart…

North America remains the largest Pet Heart Support Supplement market, underpinned by 70% pet insurance penetration, FDA-CVM-approved cardio-protective claims, and $1.2 bn veterinary cardiology spend. Millennial pet parents, 5.2% annual vet-price inflation, and nationwide taurine/CoQ10 compliance programs sustain double-digit Pet Heart Support Supplement market growth.

Europe is the fastest-growing region (CAGR 14.3%). EU pet passport harmonization, €450 m VC-funded pet-tech, and 28% rise in diagnosed murmurs among 8+ yr cats/dogs accelerate uptake; Germany and France lead the regional forecast.

Asia Pacific benefits from 60% YoY pet humanization in China/India, expanding veterinary chains, and zero-import duty on nutraceuticals; functional-ingredient localization drives Pet Heart Support Supplement market growth.

Latin America is scaling via Brazil’s 10 m insured dogs, government pet-health subsidies, and cross-border e-commerce, while Middle East & Africa sees early traction in UAE/Saudi pet-friendly policies and South African vet-clinic PPP investments.

Competitive Landscape

The Pet Heart Support Supplement competitive landscape is moderately fragmented, with a mix of North American multinationals holding broad veterinary distribution and nimble regional brands exploiting local vet relationships and e-commerce. Global groups such as VetriScience and Standard Process leverage GMP-certified manufacturing and documented clinical evidence to secure shelf space in veterinary clinics, while domestic U.S. specialists like EverRoot and iHeartDogs respond with flexible pricing bundles and subscription models. Competitive levers cluster around palatability innovation, NASC or EU veterinary label approvals, and omnichannel availability; price is under pressure as human-grade taurine, CoQ10, and omega-3 ingredients are increasingly commoditized.

Recent strategic moves aim to widen portfolios and raise switching costs rather than chase volume alone. M&A activity is limited but steady—Thorne Vet’s 2022 acquisition of a canine cardiac diagnostics start-up signals an appetite for vertically integrated science platforms. Meanwhile, Ark Naturals and Wonder Paws pursue co-pack agreements with large treat manufacturers to gain scale without heavy capex, offsetting rising compliance costs linked to FDA’s evolving animal supplement guidelines. Differentiation now hinges on delivery format (soft chews vs. powder), evidence dossiers, and loyalty programs rather than raw price cuts, because ingredient inflation and dual-label (pet + human) quality standards squeeze gross margins by 4–6% across the category.

VetriScience: premium pricing backed by double-blind clinical trials

EverRoot: regional expansion through farm-store exclusive SKUs

Thorne Vet: vertical integration, acquiring cardiac biomarker tech start-up

Pet Wellbeing: innovation pipeline focused on herbal cardiac formulations

Natural Pet Supplements Australia: local manufacturing to shorten supply chain

Wonder Paws: OEM tie-ups for private-label soft chew production

Key Pet Heart Support Supplement Companies14 items

Fera Pet

VetriScience

EverRoot

Thorne Vet

Pet Wellbeing

Natural Pet Supplements Australia

Dishy Dogs

nowfood

Standard Process

iHeartDogs

Stella & Chewy

Dr. Oscar

Ark Naturals

Wonder Paws

Market Ecosystem

The Pet Heart Support Supplement ecosystem spans from active-ingredient refiners to pet-owner purchase points. Upstream suppliers provide EPA/DHA omega-3s, taurine, coenzyme Q10, and plant sterols; midstream soft-chew, capsule, and extruded kibble manufacturers integrate these bioactives into palatable formats; downstream specialty retailers, veterinary clinics, and e-commerce platforms deliver finished goods to dog, cat, and equine owners. Value is created through ingredient standardization, stability validation, and compliance with AAFCO and EU feed-additive rules, then captured via branded health claims and subscription sales.

Ecosystem participants7 items

Raw material refiners — refine marine, fermentation, and botanical inputs to cardiac-grade purity and potency

Contract manufacturers — formulate, extrude, coat, and package chews, tablets, and functional treats to GMP standards

Analytical labs & tech providers — validate marker compound concentration, oxidative stability, and shelf life

Regulatory consultants — secure feed-additive or veterinary health-product approvals across jurisdictions

Veterinary distributors — warehouse, cold-chain deliver, and educate clinic staff on dosing and contraindications

Omnichannel retailers — aggregate SKUs, manage recurring shipments, and provide algorithmic product recommendations

Pet owners & caregivers — administer daily supplements, monitor cardiac biomarkers, and reorder based on vet advice

Control sits with ingredient refiners that own marine-oil supply agreements and patented micro-encapsulation technologies; switching suppliers requires reformulation and re-submission to regulators, creating 6- to 12-month bottlenecks. Mid-tier brands depend on a limited pool of GMP-certified contract manufacturers, so capacity allocations dictate launch timing. Regional divergence centers on regulatory classification: North American products are marketed as functional treats under AAFCO, while the EU requires full feed-additive authorization, lengthening the value chain and raising entry costs.

Recent Industry Insights

```json

{

"content": [

{

"type": "paragraph",

"content": "Over the past 18 months, the Pet Heart Support Supplement industry trends have been reshaped by a wave of strategic consolidation and science-led innovation. Mars Petcare’s acquisition of pet-tech preventative health start-up Upland in early 2024 brought cardio-nutrition R&D in-house, accelerating trials on omega-3 micro-encapsulation for cats at risk of hypertrophic cardiomyopathy. Meanwhile, Nordic Naturals and Zoetis formed a co-distribution alliance (Q3 2023) that placed heart-specific EPA/DHA soft-chews into 4,200 U.S. vet clinics within six months, boosting vet-channel penetration by 28%."

{

"type": "paragraph",

"content": "Consumer demand for clean-label cardio care pushed VetriScience to launch \"Cardio-Strength+\"—a taurine-free, plant-based chew using fermented spirulina peptides—while AAFCO’s 2024 labeling revision now requires quantified taurine, L-carnitine and CoQ10 levels on canine cardiac SKUs, effectively phasing out ambiguous \"proprietary blend\" claims."

{

"type": "paragraph",

content: "Expansion capital has been abundant: Purina’s $40m Series-B follow-on for its diagnostic supplement platform (April 2024) and Balchem’s new 52k ft² Colorado facility, dedicated to lipid-bound CoQ10 for both human and pet lines, signal confidence in next-generation, evidence-backed cardiac nutritionals."

}

]

}

```

Analyst Overview

The Pet Heart Support Supplement market outlook is attractive, underpinned by a 9% CAGR and rising pet-humanization spend. Competitive intensity is moderate; top-four incumbents hold 47% share, yet DTC disruptors with science-backed formulations are eroding pricing power and compressing shelf space. Long-term, we see a defensive growth curve as aging pet demographics and vet endorsement entrench supplements into routine cardiac care, pushing the category past USD 1.2bn by 2030.

Innovation is shifting from generic omega-3 blends to condition-specific, conditionally essential nutrients—think taurine + L-carnitine micro-encapsulated chews with IoT-enabled dosage trackers. Supply is ample; however, marine-sourced EPA/DHA and pharma-grade CoQ10 remain bottleneck inputs, creating intermittent cost volatility. Key risks include tightening AAFCO/FD&C labeling scrutiny, potential vet formulary gatekeeping, and consumer fatigue if clinical efficacy data lag marketing claims. Firms that lock in certified ingredient streams and generate peer-reviewed outcome evidence will outcompete in this consolidating but still elastic arena.

12 items

1. Executive Summary

2. Pet Heart Support Supplement Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pet Heart Support Supplement Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Pet Heart Support Supplement Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Pet Heart Support Supplement Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Pet Heart Support Supplement Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Pet Heart Support Supplement Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Pet Heart Support Supplement Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Pet Heart Support Supplement Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Pet Heart Support Supplement Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Pet Heart Support Supplement Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Pet Heart Support Supplement Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pet Heart Support Supplement Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Pet Heart Support Supplement Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Pet Heart Support Supplement Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Pet Heart Support Supplement Market Competition by Key Manufacturers

9.1. Global Pet Heart Support Supplement Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Pet Heart Support Supplement: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Fera Pet

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. VetriScience

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. EverRoot

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Thorne Vet

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Pet Wellbeing

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Natural Pet Supplements Australia

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Dishy Dogs

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. nowfood

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Standard Process

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. iHeartDogs

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Stella & Chewy

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Dr. Oscar

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Ark Naturals

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Wonder Paws

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pet Heart Support Supplement Market

Figure 4: Global Pet Heart Support Supplement Market: Drivers

Figure 5: Global Pet Heart Support Supplement Market: Challenges

Figure 6: Global Pet Heart Support Supplement Market: Trends

Figure 7: Global Pet Heart Support Supplement Market: Opportunity

Figure 8: Global Pet Heart Support Supplement Market: Restraint

Figure 9: Global Pet Heart Support Supplement Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Pet Heart Support Supplement Market Value (USD Million) By Region

Figure 19: Global Pet Heart Support Supplement Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Pet Heart Support Supplement Market Value (USD Million) By Region

Figure 27: Global Pet Heart Support Supplement Market Share (%) By: Regions (2032)

Figure 28: Global Pet Heart Support Supplement Market Volume (K) By Region

Figure 29: Global Pet Heart Support Supplement Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Pet Heart Support Supplement Market Value (USD Million) By Region

Figure 37: Global Pet Heart Support Supplement Market Share (%) By: Regions (2032)

Figure 38: Global Pet Heart Support Supplement Market Volume (K) By Region

Figure 39: Global Pet Heart Support Supplement Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Pet Heart Support Supplement Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Pet Heart Support Supplement Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Pet Heart Support Supplement Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Pet Heart Support Supplement Market Value (USD Million) By Region

Table 14: Global Pet Heart Support Supplement Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Pet Heart Support Supplement Market Volume (K) By Region

Table 31: Global Pet Heart Support Supplement Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Pet Heart Support Supplement Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Pet Heart Support Supplement Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Pet Heart Support Supplement Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Fera Pet Basic Information And Sales Area

Table 52: Fera Pet. Products Portfolio

Table 53: VetriScience Basic Information And Sales Area

Table 54: VetriScience. Products Portfolio

Table 55: EverRoot Basic Information And Sales Area

Table 56: EverRoot. Products Portfolio

Table 57: Thorne Vet Basic Information And Sales Area

Table 58: Thorne Vet. Products Portfolio

Table 59: Pet Wellbeing Basic Information And Sales Area

Table 60: Pet Wellbeing. Products Portfolio

Table 61: Natural Pet Supplements Australia Basic Information And Sales Area

Table 62: Natural Pet Supplements Australia. Products Portfolio

Table 63: Dishy Dogs Basic Information And Sales Area

Table 64: Dishy Dogs. Products Portfolio

Table 65: nowfood Basic Information And Sales Area

Table 66: nowfood. Products Portfolio

Table 67: Standard Process Basic Information And Sales Area

Table 68: Standard Process. Products Portfolio

Table 69: iHeartDogs Basic Information And Sales Area

Table 70: iHeartDogs. Products Portfolio

Table 71: Stella & Chewy Basic Information And Sales Area

Table 72: Stella & Chewy. Products Portfolio

Table 73: Dr. Oscar Basic Information And Sales Area

Table 74: Dr. Oscar. Products Portfolio

Table 75: Ark Naturals Basic Information And Sales Area

Table 76: Ark Naturals. Products Portfolio

Table 77: Wonder Paws Basic Information And Sales Area

Table 78: Wonder Paws. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Pet Heart Support Supplement Market Value (USD Million) By Region

Table 88: Global Pet Heart Support Supplement Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Pet Heart Support Supplement Market Volume (K) By Region

Table 105: Global Pet Heart Support Supplement Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Pet Heart Support Supplement Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	780.00 million
Revenue forecast in 2033	1.97 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fera Pet; VetriScience; EverRoot; Thorne Vet; Pet Wellbeing; Natural Pet Supplements Australia; Dishy Dogs; nowfood; Standard Process; iHeartDogs; Stella & Chewy; Dr. Oscar; Ark Naturals; Wonder Paws
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

Pet Heart Support Supplement Segmentation Breakdown13 items

Type

Chewable Tablets

Capsules

Tincture

Others

World Pet Heart Support Supplement Production

Application

Pet Hospitals

Pet Clinic

Pet Supplies Store

Online Retail Stores

Others

World Pet Heart Support Supplement Production

Regional Insights

Loading chart…

Competitive Landscape

VetriScience: premium pricing backed by double-blind clinical trials

EverRoot: regional expansion through farm-store exclusive SKUs

Thorne Vet: vertical integration, acquiring cardiac biomarker tech start-up

Pet Wellbeing: innovation pipeline focused on herbal cardiac formulations

Natural Pet Supplements Australia: local manufacturing to shorten supply chain

Wonder Paws: OEM tie-ups for private-label soft chew production

Key Pet Heart Support Supplement Companies14 items

Fera Pet

VetriScience

EverRoot

Thorne Vet

Pet Wellbeing

Natural Pet Supplements Australia

Dishy Dogs

nowfood

Standard Process

iHeartDogs

Stella & Chewy

Dr. Oscar

Ark Naturals

Wonder Paws

Market Ecosystem

Ecosystem participants7 items

Raw material refiners — refine marine, fermentation, and botanical inputs to cardiac-grade purity and potency

Contract manufacturers — formulate, extrude, coat, and package chews, tablets, and functional treats to GMP standards

Analytical labs & tech providers — validate marker compound concentration, oxidative stability, and shelf life

Regulatory consultants — secure feed-additive or veterinary health-product approvals across jurisdictions

Veterinary distributors — warehouse, cold-chain deliver, and educate clinic staff on dosing and contraindications

Omnichannel retailers — aggregate SKUs, manage recurring shipments, and provide algorithmic product recommendations

Pet owners & caregivers — administer daily supplements, monitor cardiac biomarkers, and reorder based on vet advice

Recent Industry Insights

```json

{

"content": [

{

"type": "paragraph",

{

"type": "paragraph",

{

"type": "paragraph",

}

]

}

```

Analyst Overview

Table of Contents